• BELIMUMAB chembl:CHEMBL1789843 ApprovedAntineoplasticImmunotherapy

    Alternate Names:

    BEL114333
    GSK-1550188
    LYMPHOSTAT-B BENLYSTA
    BEL-114333
    BENLYSTA
    LYMPHOSTAT-B
    GSK1550188
    BELIMUMAB
    HGS-1006
    BELIMUMAB (GENETICAL RECOMBINATION)
    HGS1006
    chembl:CHEMBL1789843
    chemidplus:356547-88-1
    rxcui:1092437
    drugbank:08879

    Drug Info:

    FDA Approval approved
    Drug Class monoclonal antibody
    Drug Indications antiinflammatory agent,DMARD
    FDA Approval Lupus erythematosus
    Drug Class Therapeutic Antibodies
    (2 More Sources)

    Publications:

    • Version: 20-Jun-2017

    Alternate Names:
    BELIMUMAB Generic Name
    BENLYSTA Trade Name

    Drug Info:
    Drug Class Therapeutic Antibodies
    FDA Approval Lupus erythematosus

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent,DMARD
    Drug Class monoclonal antibody
    FDA Approval approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D05IQX TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications: